Companies · Medical Devices
WASHINGTON · Medical Devices · refined from filed group “Other” · https://www.hartmann.info/en
Diligence memoA one-page analyst read on Hartmann & Benz LLC — recommendation, valuation, rhythm, risks.→Hartmann & Benz LLC has raised $600M over 1 round; too few niche peers to rank its valuation yet.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Hartmann & Benz LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Hartmann & Benz LLC is one of 233 Medical Devices companies tracked from WASHINGTON. By capital raised it ranks among the largest (ahead of 100% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Medical knowledge, solutions and products for consumers and professionals in the areas of wound, incontinence, disinfection and surgical needs.
Medical knowledge, solutions and products for consumers and professionals in the areas of wound, incontinence, disinfection and surgical needs. Visit our website & webshop hartmanndirect.com for private customers to explore incontinence, desinfection, wound and skin care products.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B, Series C, Series D+ — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 14%.
Round size and date are reported; the stage label is inferred from round size (latest is Growth/Late — a round over $400M). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 100% of sector peers (real $). Modeled value above 100% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Growth/Late | $600.0M | 2022-11-14 | $6.0B | $10.4B | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Mustapha Hasni | — | — | 2022-11 |
Hartmann & Benz LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Click Diagnostics, Inc. | Medical Devices | Series D+ | $235.0M | $2.0B | same sector |
| Minerva Surgical Inc | Medical Devices | Series B | $167.3M | $397.4M | same sector |
| Think Surgical, Inc. | Medical Devices | Series D+ | $139.6M | $88.5M | same sector |
| Digital Diagnostics Inc. | Medical Devices | Series C | $139.0M | $1.2B | same sector |
| Interpace Diagnostics Group, Inc. | Medical Devices | Series C | $113.1M | $365.0M | same sector |
| Momentis Surgical Ltd. | Medical Devices | Series C | $95.7M | $88.9M | same sector |
| Bardy Diagnostics, Inc. | Medical Devices | Series B | $89.8M | $11.9M | same sector |
| ACTIV Surgical, Inc. | Medical Devices | Series C | $86.6M | $240.1M | same sector |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Specialty Surgical Center, LLC | Hospitals and Physicians | Seed | $18.3M | 82% |
| Onkos Surgical, Inc. | Medical Devices | Series B | $595.7M | 81% |
| OBP Surgical Corp | Medical Devices | Seed | $38.4M | 81% |
| Specialty Surgical Center, LLC/NJ | Medical Devices | Pre-Seed | $1.6M | 81% |
| EDGe Surgical, Inc. | Medical Devices | Series A | $3.6M | 80% |
| IC Surgical, Inc. | Medical Devices | Pre-Seed | $5.5M | 80% |
| Bay State Surgical Services, LLC | Medical Devices | Pre-Seed | $10.9M | 80% |
| CAIRA Surgical Corp | Medical Devices | Series A | $85.4M | 80% |
See where Hartmann & Benz LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Hartmann & Benz LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.